Worcester, MA (December 12, 2025) — Massachusetts Biomedical Initiatives (MBI), the longest-running non-profit life sciences incubator in the Commonwealth dedicated to creating a biomanufacturing hub in Central Massachusetts, and QMB, Inc., are celebrating the progress of their three-year DNA Level sponsorship partnership. QMB, Inc. is a Boston-based, emerging leader in AI-driven MedTech SaaS. Founded by a Worcester native, QMB is the developer of QualiVerse®, a Regulatory Intelligence Engine that helps medical device innovators achieve compliance, accelerate new product development, and scale safely to market.

As part of the 3-year partnership, QMB has actively engaged with MBI’s startup ecosystem, including exhibiting at MBI’s vendor fair in October 2025. The collaboration continues to provide MBI member companies with access to early-stage regulatory guidance, helping startups anticipate regulatory challenges and accelerate and de-risk their path to commercialization.

“This partnership reflects our continued commitment to supporting our companies from concept to clinical trials,” said Jon Weaver, President & CEO of MBI. “QMB shares our entrepreneurial spirit and our belief in the power of startups to drive innovation, bring lifesaving products to patients, and grow the regional economy. Their support continues to be a valuable asset to the companies at MBI and within our region.”

By embedding early support for FDA strategy and compliance, MBI startups gain a competitive edge at a critical point in their new product development, ensuring that when the time comes to scale, they have access to a trusted partner in QMB.

“Supporting the next wave of Central Mass entrepreneurs is deeply personal for us,” said Michel Moravia, CEO and Founder of QMB. “We’re proud to be working alongside MBI to ensure local founders have the resources and regulatory insight they need to accelerate MedTech innovation and grow with confidence. We see this as a promising and mutually rewarding collaboration that strengthens the entire regional ecosystem.”

About Massachusetts Biomedical Initiatives

Massachusetts Biomedical Initiatives (MBI) is a non-profit focused on building the Central Massachusetts bio-cluster. MBI’s mission is to be a partner for fostering innovation in the life sciences and achieves that goal through its small business incubator system, workforce development efforts, and regional economic development initiatives. It is estimated that since 2000, MBI has assisted over 200 companies that have created over 1,800 jobs, resulting in a $2 billion economic impact.

About QMB, Inc.

Quality Means Business, Inc. (QMB) builds QualiVerse®, the Regulatory Intelligence Engine for MedTech quality, regulatory, and NPD. Through AI copilots, predictive analytics, and compliance-aware automation, QMB enables innovators to launch safer, more effective devices — faster and with confidence. Follow Michel Moravia on LinkedIn for founder insights and updates from Quality in the Boardroom, QMB’s podcast spotlighting leaders shaping the future of medical innovation. Learn more at QMB.ai and QualiVerse.com.